SEC Comment Letter for Vicapsys Life Sciences, Inc. (VICP) (CIK 0001468639) (VICP) — Apr 6, 2020
Vicapsys Life Sciences, Inc. (VICP) (CIK 0001468639)
Date: April 6, 2020 · CIK: 0001468639 · Accession: 0000000000-20-002930
AI Filing Summary & Sentiment
File numbers found in text: 000-56145
Letter
April 3, 2020 Frances Toneguzzo Chief Executive Officer Vicapsys Life Sciences 1735 Buford Highway Ste. 215-113 Cumming, GA 30041 Re:Vicapsys Life Sciences, Inc. Registration Statement on Form 10-12G Filed on February 12, 2020 File No. 000-56145 Dear Ms. Toneguzzo: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
April 3, 2020
Frances Toneguzzo
Chief Executive Officer
Vicapsys Life Sciences
1735 Buford Highway
Ste. 215-113
Cumming, GA 30041
Re:Vicapsys Life Sciences, Inc.
Registration Statement on Form 10-12G
Filed on February 12, 2020
File No. 000-56145
Dear Ms. Toneguzzo:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences